Cmed opens its second US office in Durham

To meet the needs of our customers and our growing business, Cmed Inc is delighted to announce the opening of its second US office in Durham, North Carolina.

David Connelly, CEO of Cmed, said, “We are very excited about establishing a second US base and our new offices in Durham, close to Research Triangle Park (RTP), are the perfect location for Cmed. RTP continues to be a model for innovation, education, and economic development and our new offices will allow us to draw on the tremendously skilled workforce in the Raleigh-Durham-Chapel Hill area, and to get close to our customers to provide even better service.

Our priority will be to build our Biostatistics team, but we will also continue to grow our Clinical and Data Management capabilities in line with our customers’ needs. The goal is to establish a true ‘state of the art’, integrated clinical operations group providing clinical, data management and biostatistics services around our sophisticated Timaeus technology. This will enable Cmed to offer genuinely cost effective services even in such operationally challenging areas as Adaptive Trial Design and the complexities of oncology.”

Cmed established its first US foothold in 2001 with offices in New Providence, New Jersey, before quickly moving to a larger office in Murray Hill, New Jersey.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.